BioSig Technologies Plunges 11.72% on Merger News

BioSig Technologies' stock price dropped by 11.72% in pre-market trading on May 6, 2025, following the announcement of a strategic merger with Streamex Exchange.

BioSig Technologies has entered into a Letter of Intent (LOI) to merge with Streamex Exchange Corporation, aiming to create a publicly listed real-world asset tokenization company. This merger represents a significant shift for BioSig, transitioning from its medical technology focus to blockchain technology and digital asset tokenization. Streamex's platform, which facilitates the tokenization of real-world assets, will be integrated with BioSig's operations, enhancing capital availability and expanding investment opportunities.

The proposed all-stock transaction will see Streamex's stockholders owning approximately 75% of the merged company's common stock, while BioSig's current stakeholders will hold the remaining equity. The merger is expected to bring seasoned executives from the financial, commodities, and blockchain sectors to the merged entity, including Henry McPhie as the new CEO and Morgan Lekstrom as the Chairman of the Board. This strategic move is anticipated to unlock new opportunities for investors and institutions globally, supported by the expertise of advisors such as Frank Giustra and Mathew August.